3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Sarcoma
3
Melanoma
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Pain
2
Osteosarcoma
2
Neoplasm Metastasis
2
Kidney Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Pheochromocytoma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Intraocular Lymphoma
1
Esthesioneuroblastoma, Olfactory
1
Colonic Neoplasms
1
Chondrosarcoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms, Male
1
Interventions
Cisplatin
18
pembrolizumab
12
Paclitaxel
9
Carboplatin
9
Radiotherapy
5
Gemcitabine
4
Fluorodeoxyglucose F18
4
Colposcopy
4
Brachytherapy
4
fludarabine
3
durvalumab
3
Surveys and Questionnaires
3
Radiation
3
Flow Cytometry
3
Cyclophosphamide
3
Biopsy
3
Bevacizumab
3
toripalimab
2
fludarabine phosphate
2
atezolizumab
2
aldesleukin
2
adavosertib
2
Zoledronic Acid
2
Topotecan
2
Nivolumab
2
Neoadjuvant Therapy
2
Microarray Analysis
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Interleukin-2
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Uterine Cervical Neoplasms
×
Cryosurgery
×
Clear all
NCT00233727
2015-07-09
SAT
Columbia University
Phase 3
Terminated
7,123 enrolled